Sort by

Send to

Choose Destination

Search results

Items: 14


In reply to 'Active case finding for tuberculosis: what is the most informative measure for policy makers?'.

Sekandi JN, List J, Luzze H, Yin X, Dobbin K, Corso PS, Oloya J, Okwera A, Whalen CC.

Int J Tuberc Lung Dis. 2014 Mar;18(3):377-8. doi: 10.5588/ijtld.13.0924-2. No abstract available.


Yield of undetected tuberculosis and human immunodeficiency virus coinfection from active case finding in urban Uganda.

Sekandi JN, List J, Luzze H, Yin XP, Dobbin K, Corso PS, Oloya J, Okwera A, Whalen CC.

Int J Tuberc Lung Dis. 2014 Jan;18(1):13-9. doi: 10.5588/ijtld.13.0129. Erratum in: Int J Tuberc Lung Dis. 2014 Jun;18(6):754.


Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.

Mukonzo JK, Okwera A, Nakasujja N, Luzze H, Sebuwufu D, Ogwal-Okeng J, Waako P, Gustafsson LL, Aklillu E.

BMC Infect Dis. 2013 Jun 4;13:261. doi: 10.1186/1471-2334-13-261.


Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda.

Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, Cave MD, Whalen CC, Johnson JL, Boom WH, Joloba M; Tuberculosis Research Unit.

Int J Tuberc Lung Dis. 2013 Mar;17(3):361-7. doi: 10.5588/ijtld.11.0692.


The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis.

Mayanja-Kizza H, Wu M, Aung H, Liu S, Luzze H, Hirsch C, Toossi Z.

Scand J Immunol. 2009 Jun;69(6):516-20. doi: 10.1111/j.1365-3083.2009.02246.x.


Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention.

Srikantiah P, Lin R, Walusimbi M, Okwera A, Luzze H, Whalen CC, Boom WH, Havlir DV, Charlebois ED.

Int J Tuberc Lung Dis. 2007 Feb;11(2):168-74.


Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala.

Okwera A, Johnson JL, Luzze H, Nsubuga P, Kayanja H, Cohn DL, Nunn P, Ellner JJ, Whalen CC, Mugerwa RD.

Int J Tuberc Lung Dis. 2006 Jan;10(1):39-44.


A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.

Elliott AM, Luzze H, Quigley MA, Nakiyingi JS, Kyaligonza S, Namujju PB, Ducar C, Ellner JJ, Whitworth JA, Mugerwa R, Johnson JL, Okwera A.

J Infect Dis. 2004 Sep 1;190(5):869-78. Epub 2004 Jul 29.


Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.

Collins KR, QuiƱones-Mateu ME, Wu M, Luzze H, Johnson JL, Hirsch C, Toossi Z, Arts EJ.

J Virol. 2002 Feb;76(4):1697-706.


Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation.

Toossi Z, Johnson JL, Kanost RA, Wu M, Luzze H, Peters P, Okwera A, Joloba M, Mugyenyi P, Mugerwa RD, Aung H, Ellner JJ, Hirsch CS.

J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):1-8.


Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda.

Luzze H, Elliott AM, Joloba ML, Odida M, Oweka-Onyee J, Nakiyingi J, Quigley M, Hirsch C, Mugerwa RD, Okwera A, Johnson JL.

Int J Tuberc Lung Dis. 2001 Aug;5(8):746-53.


Macrophage-activating cytokines in human immununodeficiency virus type 1-infected and -uninfected patients with pulmonary tuberculosis.

Mayanja-Kizza H, Johnson JL, Hirsch CS, Peters P, Surewicz K, Wu M, Nalugwa G, Mubiru F, Luzze H, Wajja A, Aung H, Ellner JJ, Whalen C, Toossi Z.

J Infect Dis. 2001 Jun 15;183(12):1805-9. Epub 2001 May 17.


HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosis.

Hodsdon WS, Luzze H, Hurst TJ, Quigley MA, Kyosiimire J, Namujju PB, Johnson JL, Kaleebu P, Okwera A, Elliott AM.

AIDS. 2001 Mar 9;15(4):467-75.


Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis.

Hirsch CS, Toossi Z, Johnson JL, Luzze H, Ntambi L, Peters P, McHugh M, Okwera A, Joloba M, Mugyenyi P, Mugerwa RD, Terebuh P, Ellner JJ.

J Infect Dis. 2001 Mar 1;183(5):779-88. Epub 2001 Feb 8.

Items per page

Supplemental Content

Write to the Help Desk